XML 73 R62.htm IDEA: XBRL DOCUMENT
v3.24.3

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2024 | Sep. 30, 2023 | Sep. 30, 2024 | Sep. 30, 2023
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 4,209 | $ 3,527 | $ 12,186 | $ 10,515
MedSurg |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,479 | 1,341 | 4,373 | 3,981
Cardiovascular |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 2,731 | 2,185 | 7,813 | 6,534
United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 2,593 | 2,099 | 7,317 | 6,212
United States | MedSurg |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,007 | 898 | 2,941 | 2,655
United States | Cardiovascular |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,586 | 1,201 | 4,377 | 3,557
International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,616 | 1,427 | 4,869 | 4,303
International [Member] | MedSurg |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 472 | 443 | 1,433 | 1,326
International [Member] | Cardiovascular |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,145 | 984 | 3,436 | 2,977
Endoscopy [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 678 | 629 | 1,996 | 1,836
Endoscopy [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 417 | 382 | 1,227 | 1,118
Endoscopy [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 261 | 247 | 769 | 719
Urology [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 532 | 483 | 1,570 | 1,437
Urology [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 379 | 341 | 1,098 | 1,007
Urology [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 153 | 142 | 473 | 430
Neuromodulation [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 268 | 229 | 807 | 708
Neuromodulation [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 211 | 175 | 616 | 530
Neuromodulation [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 57 | 55 | 191 | 177
Interventional Cardiology Therapies |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 661 | 583 | 1,977 | 1,803
Interventional Cardiology Therapies | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 212 | 182 | 608 | 554
Interventional Cardiology Therapies | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 449 | 401 | 1,370 | 1,248
Watchman |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 380 | 323 | 1,103 | 930
Watchman | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 342 | 291 | 996 | 843
Watchman | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 38 | 31 | 107 | 87
Cardiac Rhythm Management [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 561 | 552 | 1,713 | 1,665
Cardiac Rhythm Management [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 349 | 355 | 1,054 | 1,057
Cardiac Rhythm Management [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 213 | 197 | 658 | 609
Electrophysiology [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 527 | 190 | 1,255 | 560
Electrophysiology [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 366 | 89 | 795 | 259
Electrophysiology [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 160 | 101 | 460 | 300
Cardiology [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 2,129 | 1,647 | 6,048 | 4,958
Cardiology [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 1,269 | 918 | 3,452 | 2,714
Cardiology [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 859 | 730 | 2,595 | 2,244
Peripheral Interventions [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 602 | 538 | 1,765 | 1,577
Peripheral Interventions [Member] | United States |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | 316 | 283 | 924 | 844
Peripheral Interventions [Member] | International [Member] |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |
Net sales | $ 285 | $ 255 | $ 841 | $ 733

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bsx_MedsurgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bsx_CardiovascularMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalEndoscopyEndoReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalUrologyandPelvicHealthReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalNeuromodulationNmReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_InterventionalCardiologyTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_WatchmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_CardiacRhythmManagementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_ElectrophysiologyEPMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalCardiologyReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=bsx_GlobalPeripheralInterventionsPiReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |